Abbott Laboratories is a U.S. health care company. It specializes in cardiovascular, diagnostics, diabetes and neuromodulation products. Abbott is also well-known for its pediatric and adult nutrition brands including Pedialyte, Ensure, Glucerna and Similac. In 2018, the company recalled its HeartMate 3 Left Ventricular Assist System and St. Jude defibrillators.
Abbott Laboratories is a U.S. health care company. It is well-known for its medical devices and nutritional products.
The company’s revenues reached over $27 million in 2017. Its best-selling products are its cardiovascular and neuromodulation products, followed by nutritionals, diagnostics and pharmaceutical drugs.
Abbott ranked No. 1 in worldwide adult nutrition and blood testing in 2017. Its new 24/7 blood glucose monitoring device, FreeStyle Libre, helped the company’s sales for diabetes products grow by 20 percent.
Abbott Laboratories has over 125 years’ experience in the consumer health care and pharmaceutical industry. The company has 31 manufacturing sites and 12 development centers around the world.
Abbott employs about 99,000 people in over 150 countries. Its headquarters is in Chicago, Illinois at Abbott Park.
Miles D. White is Abbott Laboratories’ current CEO.
Abbott got its start in 1888. Practicing physician and drug store owner Wallace Abbott founded Abbott Alkaloidal Company.
Abbott made about $2,000 in its first year. The company was incorporated in 1894.
In 1907, Abbott expanded its reach outside the U.S. with the opening of an office in London, England. Abbott produced its first synthetic medicine, Chlorazene, in 1916. This antiseptic medicine was used to treat wounded World War I soldiers.
Abbott’s breakthroughs and acquisitions continued into the 21st century. Abbott officially separated from its sister company, AbbVie, in 2013.
Abbott wanted to focus on heart stents and other medical devices. AbbVie’s main concentration is pharmaceutical drugs.
Abbott acquired St. Jude Medical and Alere Inc. in 2017. It paid more than $28 billion for both companies. Abbott wanted to expand its reach and boost its diagnostics presence in the U.S. and worldwide.
Abbott is the maker of many popular products in the therapeutic areas of cardiovascular, diabetes, diagnostics, neuromodulation, nutrition and pharmaceuticals.
Some of its well-known brands include Similac, PediaSure, Pedialyte, Brufen, Klacid, Alinity, Ensure, FreeStyle, iStat and MitraClip.
The company claims to be a market leader in blood screening, adult and pediatric nutrition, left ventricular assist devices, remote heart failure monitoring, and point-of-care testing.
Abbott has faced lawsuits over its drug Tricor, FreeStyle diabetes products and St. Jude defibrillators.
Just months after acquiring St. Jude Medical, Abbott found itself mixed up in a nationwide class action suit.
The lawsuit claims that St. Jude Medical knew about a battery-depletion defect in some of its cardiac defibrillators starting in 2011, but the company did not adequately report the risk.
Instead, the company waited almost five years before initiating a recall of the faulty devices in October 2016.
The class action suit was filed on behalf of public and private health insurance payers who had to pay for the high-priced defective devices and surgeries. Plaintiffs are seeking just over $9.9 million in damages.
The parents of a diabetic woman who died after using Abbott’s FreeStyle test strips and blood glucose monitor system sued Abbott.
They filed the wrongful death lawsuit in Cook County Circuit Court in Chicago, Illinois, in December 2014.
Abbie Harper died in November 2013. Abbott recalled the test strips Harper was using four days after her death.
Harper’s parents alleged that the defective test strips provided inaccurately low blood glucose results. This caused Harper to receive too little insulin from her insulin pump made by Walgreen, a different manufacturer also named in the lawsuit.
Harper went two days with receiving too little insulin before she died from diabetes-related complications.
Depakote lawsuits claim children suffered birth defects because their mothers took Depakote during pregnancy. Abbott rid itself of all rights and responsibilities for Depakote when it separated from AbbVie.
In late-2008, Abbott agreed to pay $184 million to settle antitrust claims brought by competitor pharmaceutical companies, drug stores and other purchasers.
Competitors who sued Abbott included Teva Pharmaceuticals and Impax Laboratories. They claimed Abbott blocked cheaper generic versions of its cholesterol medication Tricor from making their way to consumers.
Abbott reached another settlement in April 2009 to resolve the last of the claims. That settlement cost Abbott another $250 million. Tricor brought in more than $1 billion in sales for Abbott in 2007.
Humira lawsuits blame the drug for causing infection and cancer. Patients have sued Abbott and AbbVie over the drug.
Abbott recalled some of its popular medical devices and other products after they caused patient injuries and deaths.
Please seek the advice of a medical professional before making health care decisions.
Calling this number connects you with Wilson and Peterson, LLP or one of its trusted legal partners. A law firm representative will review your case for free.
Wilson and Peterson, LLP funds Drugwatch because it supports the organization’s mission to keep people safe from dangerous drugs and medical devices.(888) 645-1617